Abstract:Background: Cuproptosis is a newly discovered unique non-apoptotic programmed cell death distinguished from known death mechanisms like ferroptosis, pyroptosis, and necroptosis. However, the prognostic value of cuproptosis and the correlation between cuproptosis and the tumor microenvironment (TME) in lower-grade gliomas (LGGs) remain unknown. Methods: In this study, we systematically investigated the genetic and transcriptional variation, prognostic value, and expression patterns of cuproptosis-related genes (CRGs). The CRG score was applied to quantify the cuproptosis subtypes. We then evaluated their values in the TME, prognostic prediction, and therapeutic responses in LGG. Lastly, we collected five paired LGG and matched normal adjacent tissue samples from Sun Yat-sen University Cancer Center (SYSUCC) to verify the expression of signature genes by quantitative real-time PCR (qRT-PCR) and Western blotting (WB). Results: Two distinct cuproptosis-related clusters were identified using consensus unsupervised clustering analysis. The correlation between multilayer CRG alterations with clinical characteristics, prognosis, and TME cell infiltration were observed. Then, a well-performed cuproptosis-related risk model (CRG score) was developed to predict LGG patients' prognosis, which was evaluated and validated in two external cohorts. We classified patients into high- and low-risk groups according to the CRG score and found that patients in the low-risk group showed significantly higher survival possibilities than those in the high-risk group ( P <0.001). A high CRG score implies higher TME scores, more significant TME cell infiltration, and increased mutation burden. Meanwhile, the CRG score was significantly correlated with the cancer stem cell index, chemoradiotherapy sensitivity–related genes and immune checkpoint genes, and chemotherapeutic sensitivity, indicating the association with CRGs and treatment responses. Univariate and multivariate Cox regression analyses revealed that the CRG score was an independent prognostic predictor for LGG patients. Subsequently, a highly accurate predictive model was established for facilitating the clinical application of the CRG score, showing good predictive ability and calibration. Additionally, crucial CRGs were further validated by qRT-PCR and WB. Conclusion: Collectively, we demonstrated a comprehensive overview of CRG profiles in LGG and established a novel risk model for LGG patients' therapy status and prognosis. Our findings highlight the potential clinical implications of CRGs, suggesting that cuproptosis may be the potential therapeutic target for patients with LGG.

Cuproptosis-related genes signature is associated with tumor progression, PD-L1 stability and bystander T cells in esophageal carcinoma

Transcriptional and genetic alterations of cuproptosis-related genes correlated to malignancy and immune-infiltrate of esophageal carcinoma

Potential impact of cuproptosis-related genes on tumor immunity in esophageal carcinoma

Cuproptosis/OXPHOS Tendency Prediction of Prognosis and Immune Microenvironment of Esophageal Squamous Cell Carcinoma: Bioinformatics Analysis and Experimental Validation

Characterization of a cuproptosis-related signature to evaluate immune features and predict prognosis in colorectal cancer

Floral ontogeny and systematic position of the Didiereaceae

Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma

Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas

Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing

Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma

Association of cuproptosis-related signature with the prognosis of patients with head and neck squamous cell carcinoma

The signature genes of cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma

[Clinical aspects and surgical treatment of arterio-mesenterial duodenal stenosis in the adult].

Clinical Features and Molecular Landscape of Cuproptosis Signature‐related Molecular Subtype in Gastric Cancer

Prognostic value and immunological function of cuproptosis-related genes in lung adenocarcinoma

Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer

An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma

[ATTEMPT AT EXTRACTION OF INFECTIOUS VIRUS FROM SPERMATOZOA OF STABILIZED MALE DROSOPHILAS].